Guangzhou DaAn Gene Co., Ltd. announces progress on its indirect controlling shareholder change. Guangzhou Pharmaceutical Holdings Limited, through its subsidiary Guangzhou Pharmaceutical Capital Co., Ltd., will acquire 100% of Guangyong Technology's equity, indirectly controlling DaAn Gene. Approvals from Guangzhou Municipal Finance Bureau and SASAC have been obtained, and the asset appraisal report is filed.
Summary generated by AI · Always verify with source document
Securities Code: 002030
Securities Abbreviation: DaAn Gene
Announcement No.: 2026-028
Guangzhou DaAn Gene Co., Ltd.
Progress Announcement on Indirect Controlling Shareholder Change
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false or misleading statements or material omissions.
I. Overview of the Matter
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.